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OBJECTIVE: The association between renal hypoxia and the development of renal injury is well established.
However, no adequate method currently exists to non-invasively measure functional changes in renal oxygenation
in normal and injured patients.
METHOD: R2* quantification was performed using renal blood oxygen level-dependent properties. Five healthy
normotensive women (50¡5.3 years) underwent magnetic resonance imaging in a 1.5T Signa Excite HDx scanner
(GE Healthcare, Waukesha, WI). A multiple fast gradient-echo sequence was used to acquire R2*/T2
* images (sixteen
echoes from 2.1 ms/slice to 49.6 ms/slice in a single breath hold per location). The images were post-processed to
generate R2* maps for quantification. Data were recorded before and at 30 minutes after the oral administration of
an angiotensin II-converting enzyme inhibitor (captopril, 25 mg). The results were compared using an ANOVA for
repeated measurements (mean ¡ standard deviation) followed by the Tukey test. ClinicalTrials.gov: NCT01545479.
RESULTS: A significant difference (p,0.001) in renal oxygenation (R2*) was observed in the cortex and medulla
before and after captopril administration: right kidney, cortex = 11.08¡0.56ms, medulla = 17.21¡1.47ms and
cortex = 10.30¡0.44ms, medulla = 16.06¡1.74ms, respectively; and left kidney, cortex = 11.79¡1.85ms, medul-
la = 17.03¡0.88ms and cortex = 10.89¡0.91ms, medulla = 16.43¡1.49ms, respectively.
CONCLUSIONS: This result suggests that the technique efficiently measured alterations in renal blood oxygenation
after angiotensin II-converting enzyme inhibition and that it may provide a new strategy for identifying the early
stages of renal disease and perhaps new therapeutic targets.
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INTRODUCTION
Despite advances in renal dialysis, there has been no
substantial change in the mortality rate of acute renal failure
over the past three decades. In contrast, over the same
period, acute myocardial infarction mortality has fallen
dramatically, from approximately 50% to 6% (1). In patients
with end-stage renal disease, the mortality rate is growing
because of the greater prevalence of hypertension and
diabetes and the increased mean age of the population (2).
Indeed, in the United States and Australia, approximately
11% of adults have some degree of chronic kidney disease
(3). In addition, the strong association between chronic
kidney disease and cardiovascular disease has led the
National Kidney Foundation and the American Heart
Association to recommend that all patients with cardiovas-
cular disease also be screened for kidney disease (4).
In cardiovascular disease, it is possible to precisely
measure blood pressure, cholesterol or glucose concentra-
tion. However, it is still very difficult to identify early-stage
renal injury, and current laboratory measurements are
insufficient for making an early diagnosis. In addition,
traditional imaging methods, although excellent for morpho-
logic assessments, are limited in detecting premature renal
functional alterations (5). The sequence of events that reduces
renal oxygenation leading to ischemia and/or kidney in-
jury is still unknown (6). Glomerular hyperfiltration (7) or
tubulointerstitial damage (8) can cause progressive and
irreversible renal failure, regardless of the initial insult. In
fact, histological studies in human kidneys showed that
tubulointerstitial oxygenation is modified before structural
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microvascular damage takes place. This observation indi-
cates that morphological changes begin in a very early stage
of kidney disease (9). At this stage, it is not possible to
diagnose renal pathology using the methods available. Thus,
a method for detecting the early stages of renal functional
changes would be very useful for the early treatment of renal
disease. Unfortunately, renal biopsy is the only current
method of confirm functional alteration (5).
From the late 1980s, when Brezis (1991) (10) inserted
microelectrodes into the Sprague-Dawley rats renal parench-
yma to demonstrate hypoxic changes during acute kidney
injury, to the 1990s, when Prasad introduced blood oxygen
level-dependent (BOLD) magnetic resonance imaging (MRI)
to the study of renal blood flow (11), several different factors
have been blamed for the slow progress of the prevention
and treatment of acute or chronic renal failure.
There is no doubt that the renin angiotensin system (RAS)
is useful to preserve peritubular capillary perfusion under
normal situations (12). However, when it is excessively
stimulated, the RAS can induce renal hypoxia, reducing the
efficiency of oxygen diffusion in renal tissue and provoking
functional (13) and structural changes, damage to the renal
vasculature and fibrosis (14).
In the present study, we measured the intra-renal effect of
ACE inhibition on healthy subjects using a sensitive BOLD-
MRI method that uses deoxygenated hemoglobin as an
endogenous contrast agent. The ratio of oxyhemoglobin
(diamagnetic) to deoxyhemoglobin (paramagnetic) is pro-
portional to the partial oxygen pressure (pO2). The BOLD
signal is estimated using the transverse relaxation rate R2*
(1/T2*) and can be considered a sensitive indicator of tissue
pO2. However, an inverse ratio also exists; when this signal
is increased, renal oxygenation is decreased, and vice versa
(11,15).
Therefore, considering that angiotensin II (Ang II) reduces
renal blood flow, (16-17) we hypothesized that partial ACE
inhibition would increase the BOLD-MRI signal in renal
tissue. The study of the mechanism underlying this putative
process and the responses to ACE inhibition is of consider-
able importance. Understanding the mechanisms by which
the kidney adapts to the effects of the RAS in healthy
subjects will be useful for the early detection of renal disease
and for the development of new therapies to decrease the
progression of the disease and its consequences.
METHODS
Subjects
The study was conducted under protocol (n˚ 4111/08),
approved by the Ethics Committee of the Instituto de
Cardiologia do Rio Grande do Sul-Fundac¸a˜o Universita´ria de
Cardiologia/Brazil. After providing informed consent, five
healthy female volunteers (50¡5.3 years old) participated in
the study. None of the subjects were taking any medica-
tions, and they were asked to abstain from food and water
overnight. All measurements were performed in the late
morning.
After a baseline BOLD-MRI acquisition, the subjects were
given an oral ACE inhibitor (captopril 25 mg). Thirtyminutes
after captopril administration, without moving from the
scanner, blood pressure was measured and a second BOLD
acquisitionwas performed to detect possible changes in renal
oxygenation. Data were collected by two radiologists and
interpreted by a physician and a physiologist.
MR Imaging Technique
Images were acquired using a 1.5T HDx instrument
(Sigma, GE Healthcare, Waukesha, WI) and an 8-channel
body coil.
Localizer images were performed in the axial and sagittal
planes following the long axis of both kidneys, using the fast
spoiled gradient echo (FSPGR) technique while the patients
held their breath.
Oblique axial and coronal reference images were acquired
to construct color maps following approximately the short
and long axes of both kidneys using FSPGR with the follow-
ing parameters: field of view (FOV)=40 cm, matrix 2566128,
slice thickness= 5 cm, slice gap 6 cm, 3 slices per plane in one
breath hold, repetition time (RT)=150ms, echo time (ET=min
full, angle degrees (FLIP)= 90, band width (rBW)=62KHz,
1NEX. This sequence provides an excellent contrast between
the cortex and the medulla and avoids the unnecessary use of
contrast agents.
BOLD-sensitive images were acquired using the multiple
echo FGRE sequence with the same geometrical parameters.
The reference images considered the following parameters:
TR= 60 ms, FLIP = 30, rBW=60 KHz, 16 echoes from TE=
2.1 ms until 49.6 ms, an echo interval of 3.2 ms, 1 NEX.
BOLD imaging Data Processing
Bold image processing was performed using the Functool
R2* module for R2*/T2* fitting, assuming single exponential
decay without constant offset at AW4.3 (GE Healthcare).
For visualization and quantification, R2* parametric maps
were generated for each slice (11,18-19). A Puh-Thallium
color table was used because the data had a dynamic range
with aminimumvalue set at 7.0/sec and amaximumvalue at
23/sec. The color ranged from blue to red from the minimum
R2* to the maximum R2*, respectively. Green/yellow color-
ing represents intermediate R2*. When a position mismatch
occurred due to a different breath hold state, anatomical fat-
suppressed FSPGR images were used as transparent refer-
ences over a parametric map or the original BOLD images.
Three slices were acquired, and the slice that provided the
best differentiation between the cortex and the medulla and
the minimum partial volume was selected for quantifica-
tion. A total of six regions of interest (ROIs) with a pixel size
of nine were used for each plane; three regions were
positioned at the cortex and three were positioned at the
medulla.
The ROIs were positioned at the cortex according to the
anatomical reference image (light gray) and blue on the
parametric map. The ROIs were positioned at the medulla
using either the anatomical reference image (dark gray) or the
parametricmap that showed a green, yellow and red gradient
(Figure 1). Areas with susceptibility artifacts, such as bowel
gas, and areas with renal hilum vessels were avoided.
Data analysis
The statistical significance was determined using an
analysis of variance for three repeated measures (ANOVA)
followed by the Tukey test (SPSS 12.0). The data are presented
as the mean ¡ SD. P,0.05 was considered statistically
significant.
RESULTS
Table 1 summarizes the R2* measurements of the left and
right kidney in the cortex and medulla before and after ACE
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inhibitor administration. Our results consistently indicate
that moderate ACE inhibition reduced the R2* BOLD-MRI
signal in the cortex and medulla and, therefore, increased
renal blood flow. For all subjects, the R2* values were
significantly higher in the medulla than in the cortex, and
there was a significant difference between the baseline
values and those obtained thirty minutes after ACE
inhibitor administration (Table 1). No significant differences
were observed for the values within subjects or between
subjects for the cortex and medulla in the three measure-
ments (data not shown).
The volunteers had an initial medial systolic blood
pressure of 113¡12 mmHg and a diastolic pressure of
76¡5 mmHg. Thirty minutes after captopril administration,
systolic but not diastolic blood pressure showed a modest
but significant decrease. However, the systolic blood
pressure did not significantly differ between 30 and 60
minutes after captopril administration (Table 2).
Hematocrit (37¡3.6%) and hemoglobin (12¡1.2 mEq/L)
and the plasma concentrations of sodium (139¡3.9 mEq/L),
potassium (3.8¡0.6 mEq/L) and creatinine (0.6¡0.1 mEq/
L) (n= 4) were measured in the clinical laboratory of the
Instituto de Cardiologia do Rio Grande do Sul.
DISCUSSION
The main finding of this study is that the oral adminis-
tration of a low dose of an ACE inhibitor allowed the early
detection of an increase in renal cortical and medullar
oxygenation using BOLD-MRI. This result is consistent with
the very well-established property of Ang II to decrease
renal perfusion and renal oxygenation (16-17). Ang II is
known to be responsible for the majority of the physiolo-
gical and pathological effects of RAS, and ACE inhibition
reduces Ang II formation. Ang II inhibition has been highly
successful in hypertension management and for reducing
renal disease progression (20-21).
Renal hypoxia has long been considered important in the
development of renal disease due to diabetes mellitus (22).
Ries et al. used the BOLD-MRI technique in an animal
model and observed a significant decrease in oxygenation in
the kidneys of diabetic patients compared to controls (23).
Several studies on the pathogenesis of essential hyperten-
sion have also shown that medullar blood flow reduction is
one of the most important factors in the development of
the renal disease (24). However, a chronic infusion of a
subpressor Ang II dose induces a long-term increase in BP.
This effect could be associated with the afferent arteriolar
reactivity to Ang II and might be present in the early stages
of hypertension (25). These findings and the fact that Ang II
decreases renal oxygenation support the utility of BOLD-
MRI for the study of the pathophysiology of hypertension
(26-27).
Thus, efforts to measure functional renal oxygenation
with the use of captopril, a renin Ang II axis inhibitor,
provide data that is relevant to the prevention and
treatment of renal diseases (26-27).
ACE inhibition and the subsequent reduction in Ang II
plasma concentration (28) most likely provoked renal
arteriolar vasodilatation and increased renal blood flow and
oxygenation. Thus, the decrease in R2* signal observed in the
cortex and medulla likely occurred due to the increase in
tissue pO2 (11,15) induced by moderate ACE inhibition.
These findings support the idea that kidney oxygen content
depends on both tubular sodium reabsorption and renal
blood flow (29) and reinforce the idea that R2* has an inverse
correlation with oxygen content and blood flow (11,30).
The results obtained using renal BOLD-MRI in the
presence of Ang II are most likely a consequence of reduced
perfusion rather than of increased renal oxygen consumption
(31). Thus, the mechanism for improving oxygenation by
Ang II blockade includes both hemodynamic changes and
efficient oxygen usage (14). These findings are consistent
with our results, which indicated that the effects of the RAS
were not exclusively associated with BP, although they were
principally associated with renal perfusion.
Figure 1 - An R2* map superimposed on the anatomic image of
the 9th echo. The lowest R2* was set to 7 Hz (blue), and the
maximum R2* was set to 23 Hz (red). The intermediate values
range from green and yellow to orange according to the color
scale on the left.
Table 1 - R2* signal (ms) in the renal cortex and medulla in five healthy kidneys before (control) and at 30 minutes after
the oral administration of an ACE inhibitor.
Cortex Medulla
Control After captopril Control After captopril
Right kidney 11.08 ¡ 0.56 10.30 ¡ 0.44{ 17.21 ¡ 1.47* 16.06 ¡ 1.74*{
Left kidney 11.79 ¡ 1.85 10.89 ¡ 0.91{ 17.03 ¡ 0.88* 16.43 ¡ 1.49*{
*p,0.001 vs. cortex (control and captopril), {p,0.001 vs. control (medulla and cortex), ACE=angiotensin-converting enzyme.
CLINICS 2012;67(7):761-765 Renal Oxygenation in Healthy Subjects
Stein A et al.
763
The right and left kidneys did not have significantly
different R2* values. It should also be emphasized that our
control R2* values are very close to those found in the
literature (11,15,32-35) for baseline measurements.
We recorded the BOLD signal after thirty minutes instead
of 60 minutes because 25 mg of captopril decreased the
systolic blood pressure (BP) equally at both time points.
Thus, our protocol predicted the second BOLD signal
acquisition after 30 minutes to avoid maintaining the
subjects in a static position inside the scanner for an
unnecessarily long period of time.
We believe that the decrease in systolic blood pressure
observed in the first 30 minutes did not interfere with renal
oxygenation. In support of this assumption, Schachinger
recently demonstrated that vasoactive substances, such as
noradrenalin and sodium nitroprusside, did not alter the
renal BOLD signal, although they were able to provoke BP
changes (31). Ang II infusion is also known to decrease the
renal BOLD signal as quickly as 10 s after the peripheral
intravenous administration of an Ang II bolus. This is
clearly faster than the arterial blood pressure response,
suggesting that it may be related to reduced renal perfusion
rather than to metabolic adjustment (31).
Several studies have also demonstrated that, at lower
concentrations, Ang II may cause greater vasoconstriction in
the medulla than in the cortex. The authors hypothesize that
this effect is likely related to the greater Ang II receptor
density in the outer medulla (36-37). In fact, we also found
that, under normal conditions, the oxygen content was
significantly higher in the cortex than in the medulla. This
result was maintained after ACE inhibition, indicating that
the physiological balance between cortical and medullar
circulation did not change after a moderate reduction of the
Ang II in the blood stream.
Our results are consistent with those of many investiga-
tors who showed that BOLD detected a higher oxygen
content in the cortex than in the medulla (11,19,34,38).
Thus, BOLD-MRI is a useful, non-invasive tool for defining
basic physiological mechanisms, and it will contribute to a
better understanding of regional oxygenation within the
kidney (39).
BOLD-MRI has opened an exciting new area for studying
renal physiopathology and has created new possibilities for
identifying the early stages of renal disease and perhaps
new therapeutic targets (40).
However, this study has several important limitations: 1-
we did not include a placebo group; 2- the subject number
was small; and 3- the study was conducted only in females.
It is also important to note that subjects were not removed
from the scanner prior to the second BOLD acquisition.
Moreover, the conditions were the same during the data
collection for all subjects, indicating that renal oxygenation
was increased after captopril administration.
There is considerable interest in developing techniques
that will enable physicians to identify and evaluate early
changes in tissue function. BOLD-MRI may be a very useful
technique for the early assessment of renal injuries in
clinical practice. More studies should be conducted to
confirm this hypothesis.
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